Deutsche Bank
STAB

Deutsche Bank’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Deutsche Bank’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4
Closed – – 5677
2017
Q4 		$0 Sell
4
-3,800
-100% -$11.6K ﹤0.01% 5211
2017
Q3 		$13K Buy
3,804
+1,500
+65% +$4.25K ﹤0.01% 4635
2017
Q2 		$6K Buy
2,304
+2,300
+57,500% +$7.51K ﹤0.01% 4732
2017
Q1 		$0 Hold
4
– – ﹤0.01% 5174
2016
Q4 		$0 Hold
4
– – ﹤0.01% 5137
2016
Q3 		$0 Sell
4
-83
-95% -$182 ﹤0.01% 5299
2016
Q2 		$0 Buy
87
+4
+5% +$9 ﹤0.01% 5408
2016
Q1 		$0 Sell
83
-335
-80% -$1.13K ﹤0.01% 5398
2015
Q4 		$0 Buy
+418
New +$1.69K ﹤0.01% 5465
2015
Q2 		– Sell
-18,526
Closed -$65K – 5514
2015
Q1 		$65K Buy
+18,526
New +$76K ﹤0.01% 4303
2013
Q4 		– Hold
0
– – – 5784
2013
Q3 		– Hold
0
– – – 5794

Other funds holding STAB

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Deutsche Bank's STAB Position: Q1 2018 in Review

Deutsche Bank sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2018, closing a stake of 4 shares.

Deutsche Bank first reported a position in STAB in Q1 2015 and held it in 10 quarters. The position peaked at $65K in Q1 2015. 16 funds tracked by Wall St. Rank hold STAB as of Q1 2018.

  • Deutsche Bank reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Deutsche Bank sold 4 Statera Biopharma, Inc. Common Stock shares in Q1 2018.
  • Deutsche Bank first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2015 and held it in 10 quarters.
  • Deutsche Bank's Statera Biopharma, Inc. Common Stock position peaked at $65K in Q1 2015.
  • 16 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2018.

Based on Deutsche Bank's 13F filing for Q1 2018, filed 15 May 2018.